BR9810620A - Terapia de bloqueio de cd154 para transplante de tecido da ilhota pancreática - Google Patents

Terapia de bloqueio de cd154 para transplante de tecido da ilhota pancreática

Info

Publication number
BR9810620A
BR9810620A BR9810620-1A BR9810620A BR9810620A BR 9810620 A BR9810620 A BR 9810620A BR 9810620 A BR9810620 A BR 9810620A BR 9810620 A BR9810620 A BR 9810620A
Authority
BR
Brazil
Prior art keywords
graft
compositions
processes
tissue transplantation
pancreatic islet
Prior art date
Application number
BR9810620-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Norma S Kenyon
Camillo Ricordi
David W Thomas
Linda Burkly
Original Assignee
Biogen Inc
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc, Univ Miami filed Critical Biogen Inc
Publication of BR9810620A publication Critical patent/BR9810620A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)
  • External Artificial Organs (AREA)
BR9810620-1A 1997-06-20 1998-06-19 Terapia de bloqueio de cd154 para transplante de tecido da ilhota pancreática BR9810620A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5026797P 1997-06-20 1997-06-20
US7726598P 1998-03-09 1998-03-09
PCT/US1998/012892 WO1998058669A2 (en) 1997-06-20 1998-06-19 Cd154 blockade therapy for pancreatic islet tissue transplantation

Publications (1)

Publication Number Publication Date
BR9810620A true BR9810620A (pt) 2000-10-03

Family

ID=26728084

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810620-1A BR9810620A (pt) 1997-06-20 1998-06-19 Terapia de bloqueio de cd154 para transplante de tecido da ilhota pancreática

Country Status (21)

Country Link
US (2) US20030072754A1 (https=)
EP (1) EP1051191B1 (https=)
JP (1) JP2002506446A (https=)
KR (1) KR100634847B1 (https=)
CN (2) CN1195546C (https=)
AT (1) ATE339966T1 (https=)
AU (1) AU730763B2 (https=)
BG (1) BG64976B1 (https=)
BR (1) BR9810620A (https=)
CA (1) CA2294154A1 (https=)
DE (1) DE69835965T2 (https=)
EA (1) EA002550B1 (https=)
EE (1) EE9900588A (https=)
HU (1) HUP0003160A3 (https=)
IL (1) IL133303A0 (https=)
IS (1) IS5273A (https=)
NO (1) NO996275L (https=)
NZ (1) NZ502052A (https=)
SK (1) SK180299A3 (https=)
TR (1) TR199903142T2 (https=)
WO (1) WO1998058669A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045958A1 (en) * 1998-03-09 1999-09-16 Biogen, Inc. Cd154 blockade therapy for modulation of immune responses to implanted devices
WO2001079555A2 (en) 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
CA2410786A1 (en) * 2000-06-02 2001-12-13 Regents Of The University Of Minnesota Immunotherapeutic method to prevent islet cell rejection
WO2001095928A2 (en) * 2000-06-09 2001-12-20 Bristol-Myers Squibb Company Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
EP1639014B1 (en) * 2003-06-13 2010-09-22 Biogen Idec MA Inc. Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
EA014226B1 (ru) 2004-07-26 2010-10-29 Байоджен Айдек Ма Инк. Антитела к cd154, их фрагменты и способы применения антител и фрагментов
WO2006054305A2 (en) * 2004-11-22 2006-05-26 Ramot At Tel Aviv University Ltd. Populations of expanded and re-differentiated adult islet beta cells capable of producing insulin and methods of generating same
WO2007047539A2 (en) * 2005-10-14 2007-04-26 Medtronic, Inc. Localized delivery to the lymphatic system
US8636995B2 (en) 2006-08-31 2014-01-28 Cardiac Pacemakers, Inc. Methods and devices to regulate stem cell homing
US8372399B2 (en) 2006-08-31 2013-02-12 Cardiac Pacemakers, Inc. Bispecific antibodies and agents to enhance stem cell homing
US8911739B2 (en) 2009-02-10 2014-12-16 Trustees Of Columbia University In The City Of New York Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide
WO2011146395A2 (en) 2010-05-17 2011-11-24 The Board Of Trustees Of The Leland Stanford Junior University Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
US10147463B2 (en) 2014-12-10 2018-12-04 Nxp Usa, Inc. Video processing unit and method of buffering a source video stream
US9512229B2 (en) * 2015-03-03 2016-12-06 Kymab Limited Synergistic combinations of OX40L antibodies for the treatment of GVHD
KR101810778B1 (ko) * 2015-06-23 2017-12-20 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
US10986309B2 (en) 2015-06-30 2021-04-20 Nxp Usa, Inc. Video buffering and frame rate doubling device and method
KR102379464B1 (ko) 2016-06-20 2022-03-29 키맵 리미티드 항-pd-l1 항체
EP3534947A1 (en) 2016-11-03 2019-09-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5474771A (en) * 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
US5683693A (en) * 1994-04-25 1997-11-04 Trustees Of Dartmouth College Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
IL125928A (en) * 1996-03-20 2002-11-10 Bristol Myers Squibb Co The use of soluble ligands that react with CTLA4, B7, CD40, gp39 and / or CD28 for the preparation of pharmaceutical preparations

Also Published As

Publication number Publication date
HK1033548A1 (en) 2001-09-07
CN1261286A (zh) 2000-07-26
EP1051191B1 (en) 2006-09-20
IL133303A0 (en) 2001-04-30
DE69835965D1 (de) 2006-11-02
EE9900588A (et) 2000-08-15
AU730763B2 (en) 2001-03-15
NZ502052A (en) 2001-01-26
JP2002506446A (ja) 2002-02-26
KR20010013965A (ko) 2001-02-26
DE69835965T2 (de) 2007-06-14
HUP0003160A2 (hu) 2001-01-29
CA2294154A1 (en) 1998-12-30
CN1195546C (zh) 2005-04-06
HUP0003160A3 (en) 2002-09-30
EA200000058A1 (ru) 2000-08-28
BG64976B1 (bg) 2006-11-30
BG104091A (en) 2000-10-31
US20070292440A1 (en) 2007-12-20
TR199903142T2 (xx) 2000-09-21
ATE339966T1 (de) 2006-10-15
NO996275L (no) 2000-02-21
KR100634847B1 (ko) 2006-10-17
IS5273A (is) 1999-11-26
AU7983098A (en) 1999-01-04
NO996275D0 (no) 1999-12-17
EP1051191A2 (en) 2000-11-15
WO1998058669A2 (en) 1998-12-30
SK180299A3 (en) 2000-06-12
CN1651919A (zh) 2005-08-10
US20030072754A1 (en) 2003-04-17
EA002550B1 (ru) 2002-06-27
WO1998058669A3 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
BR9810620A (pt) Terapia de bloqueio de cd154 para transplante de tecido da ilhota pancreática
Webb et al. Mechanism of membrane stabilization by calcium in vascular smooth muscle
Festen Intrinsic factor secretion and cobalamin absorption: physiology and pathophysiology in the gastrointestinal tract
Broyer et al. Kidney transplantation in primary oxalosis: data from the EDTA Registry
Weatherall et al. The pattern of disordered haemoglobin synthesis in homozygous and heterozygous β‐thalassaemia
Hoshi et al. Comparative endocrinology-paracrinology-autocrinology of human adult large vessel endothelial and smooth muscle cells
Ismail et al. Do changes in body temperature following envenomation by the scorpion Leiurus quinquestriatus influence the course of toxicity?
Wogensen et al. Functional and morphological effects of interleukin-1β on the perfused rat pancreas
BR0001794A (pt) Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
FR2679775A1 (fr) Medicament a base de derives soufres neutralises.
Panet et al. Fibroblast growth factor induces a transient net K+ influx carried by the bumetanide-sensitive transporter in quiescent BALB/c 3T3 fibroblasts
HARRIS et al. Immunodeficiency in chronic uremia: preliminary evidence for thymosin deficiency
WO2002094744A3 (en) Compositions comprising d-chiro inositol and sulfonylureas and methods of treatment thereof
Turlapaty et al. Tris (hydroxymethyl) aminomethane inhibits calcium uptake in vascular smooth muscle
IL95046A0 (en) Substituted 2-imidazolines and pharmaceutical compositions containing them
DK0821593T3 (da) Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein
Brewster et al. Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM)
Wizemann et al. SH-groups on the surface of pancreas cells involved in secretin stimulation and glucose-mediated secretion
Thulin et al. Aortic valve replacement with and without concomitant coronary artery bypass surgery in the elderly: risk factors related to long-term survival
JOHNSON et al. Results of treatment of renal failure by means of home hemodialysis
EP1754490A3 (en) CD 154 blockage therapy for pancreatic islet tissue transplantation in primates
OKUNUKI et al. Preparation and Some Properties of Cytochrome c1 from Heart Muscle
SHIMADA et al. Absence of interactions between histidine-rich glycoprotein and heparin-like compounds on cultured porcine aortic endothelial cells
Jaggi Siphoning Blood Glucose: A Novel Therapy
Groth et al. Diabetic patients subjected to combined pancreas and kidney transplantation or kidney transplantation alone: Outcome after 5 to 10 years

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: UNIVERSITY OF MIAMI (US) , BIOGEN IDEC MA, INC. (U

Free format text: ALTERADO DE: BIOGEN, INC.

B25D Requested change of name of applicant approved

Owner name: UNIVERSITY OF MIAMI (US) , BIOGEN IDEC MA INC. (US

Free format text: ALTERADO DE: BIOGEN IDEC MA, INC.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 37 DA LEI 9279/96, INDEFIRO O PRESENTE PEDIDO COM BASE NO ARTIGO 8O EM COMBINACAO COM O ARTIGO 13 E ARTIGO 25 DA LEI 9279/96.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.